Category: Johnson & Johnson
Johnson & Johnson's Ethicon Biosurgery business plans to add 270 jobs to its manufacturing operation in Ireland.
Johnson & Johnson (NYSE:JNJ) plans to add 270 jobs to its Ethicon Biosurgery operation in Ireland, according to the Irish Times.
Johnson & Johnson's 1st-quarter sales and earnings top expectations on another strong pharma contribution; flat sales for medical devices driven by diabetes business decline.
Johnson & Johnson (NYSE:JNJ) topped expectations with its 1st-quarter results and raised its outlook for the rest of the year, sending share prices up this morning.
Plaintiffs in product liability lawsuits against several makes of pelvic mesh products, including Boston Scientific, Johnson & Johnson and Secant Medical, want a federal judge to send the cases back to a Pennsylvania state court.
The Corporate Action Network is taking aim at Johnson & Johnson and CEO Alex Gorsky, asking for tips about wrongdoing at the company.
MASSDEVICE ON CALL — The Corporate Action Network is looking for tips to help take down healthcare giant Johnson & Johnson (NYSE:JNJ) and its CEO, Alex Gorsky.
Here's a look at some of the top legal news stories for medical device companies this week.
A Texas jury awards $1.2 million to the plaintiff in a product liability lawsuit filed over Ethicon's TVT-O pelvic mesh.
A Dallas jury split its decision in a product liability lawsuit filed over Ethicon's TVT-O pelvic mesh yesterday, awarding $1.2 million in compensatory damages to plaintiff Linda Batiste.
A federal judge in Pennsylvania upholds a lawsuit brought by surgeon and inventor Dr. Enrico Nicolo, who claims that a lawyer for Johnson & Johnson's Ethicon Endo-Surgery division tricked him into revealing trade secrets.
A lawsuit accusing an attorney of passing trade secrets along to Johnson & Johnson (NYSE:JNJ) and its Ethicon Endo-Surgery subsidiary will stand after a federal judge dismissed the law firm's bid to toss the suit.